TITLE

“Inconvenient Truths” in the Pursuit of Scientific Knowledge and Public Health

AUTHOR(S)
Relman, David A.
PUB. DATE
January 2014
SOURCE
Journal of Infectious Diseases;Jan2014, Vol. 209 Issue 2, p170
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on scientific, public health, and security implications associated with the vast knowledge about botulinum neurotoxin (BoNT) produced by the bacterium Clostridium botulinum as of January 2014. Topics discussed include severity of botulinum neurotoxin type H (BoNT/H), risk mitigation measures concerning the spread of the disease, and analysis of properties of transmissibility in BoNT/H. Also referred are some studies published within the issue addressing BoNT/H issues.
ACCESSION #
93399117

 

Related Articles

  • Botulinum Toxin in Neurogenic Detrusor Overactivity. D'Ancona, Carlos Arturo Levi; Ferreira, Rúiter Silva; Rasi, Mauricio Carneiro // International Neurourology Journal;Sep2012, Vol. 16 Issue 3, p139 

    Purpose: To evaluate the effects of botulinum toxin on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity. Methods: Thirty four adult patients with spinal cord injury and detrusor overactivity were selected. The patients received 300 units of botulinum...

  • Experiences of a Patient with Chronic Spasticity Prior to Using Botulinum Toxin (1). Yuko Fukase; Akira Okii; Toshimitsu Suga; Sawako Arai; Yoshimi Suzukamo // Annual International Conference on Cognitive & Behavioral Psycho;2014, p40 

    Title: Experiences of a patient with chronic spasticity prior to using botulinum toxin (1): An analysis using the Trajectory Equifinality Model. Introduction: In Japan, botulinum toxin (BT) injections have recently come to be used for decrease in spasticity. Although the effectiveness of this...

  • Two-Component Signal Transduction System CBO0787/ CBO0786 Represses Transcription from Botulinum Neurotoxin Promoters in Clostridium botulinum ATCC 3502. Zhen Zhang; Korkeala, Hannu; Dahlsten, Elias; Sahala, Elina; Heap, John T.; Minton, Nigel P.; Lindström, Miia // PLoS Pathogens;Mar2013, Vol. 9 Issue 3, p1 

    Blocking neurotransmission, botulinum neurotoxin is the most poisonous biological substance known to mankind. Despite its infamy as the scourge of the food industry, the neurotoxin is increasingly used as a pharmaceutical to treat an expanding range of muscle disorders. Whilst neurotoxin...

  • Effect of Whole-Body Vibration and Insulin-Like Growth Factor-I on Muscle Paralysis-Induced Bone Degeneration after Botulinum Toxin Injection in Mice. Niehoff, Anja; Lechner, Philipp; Ratiu, Oana; Reuter, Sven; Hamann, Nina; Brüggemann, Gert-Peter; Schönau, Eckhard; Bloch, Wilhelm; Beccard, Ralf // Calcified Tissue International;Apr2014, Vol. 94 Issue 4, p373 

    Botulinum toxin A (BTX)-induced muscle paralysis results in pronounced bone degradation with substantial bone loss. We hypothesized that whole-body vibration (WBV) and insulin-like growth factor-I (IGF-I) treatment can counteract paralysis-induced bone degradation following BTX injections by...

  • Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial. Shackley, Phil; Shaw, Lisa; Price, Christopher; van Wijck, Frederike; Barnes, Michael; Graham, Laura; Ford, Gary A.; Steen, Nick; Rodgers, Helen // Toxins;Dec2012, Vol. 4 Issue 12, p1415 

    Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources. This study compared the cost-effectiveness of treating post-stroke upper limb...

  • Report joins the dots. Lee, Anne // New Zealand Dairy Exporter;Nov2013, Vol. 89 Issue 4, p23 

    The article reports on the release by New Zealand multinational dairy co-operative Fonterra of a report in October 2013 providing a detailed timeline of the botulinum scare, discussion of decisions and suggestions of how each could have been handled better. The report also details deficiencies...

  • Substrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxication. Guo, Jiubiao; Waichi Chan, Edward; Chen, Sheng; Wang, Jinglin; Gao, Shan; Ji, Bin // Scientific Reports;11/20/2015, p16981 

    Potent inhibitors to reverse Botulinum neurotoxins (BoNTs) activity in neuronal cells are currently not available. A better understanding of the substrate recognition mechanism of BoNTs enabled us to design a novel class of peptide inhibitors which were derivatives of the BoNT/A substrate,...

  • Lower Eyelid Malposition: Evaluation and Treatment. Weinberg, David A. // Review of Ophthalmology;Jan2013, Vol. 20 Issue 1, p46 

    The article focuses on different disease associated with eyelids. It reports that a poor muscle tone caused due to facial nerve palsy often results in eyelid not getting back to its position is known as ectropion and highlights endoprion, the inward rolling of eyelids due to several factors...

  • 20 THINGS YOU DIDN'T KNOW ABOUT SAUSAGE. Keany, LeeAundra // Discover;Sep2011, Vol. 32 Issue 7, p80 

    The article presents a list of 20 facts about sausage, including that sausage was the first processed food, that the word comes from the Latin word for salted, and that nitrites are used to kill botulism in sausage production.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics